A STUDY led by the National University of Singapore (NUS) has found a way to use chemotherapy to shrink cancerous tumours while also minimising relapses and harmful side effects.
The team has managed to make a common chemotherapy drug, epirubicin, more effective in targeting cancer stem cells, which cause tumours to grow.
Already a subscriber? Log in
Play, subscribe and stand a chance to win prizes worth over RM39,000! T&C applies.
Cancel anytime. Ad-free. Unlimited access with perks.
